Halozyme Therapeutics in (halo 0.25 03/01/27)
13F holders, Q1 2025 (March 31)17holders +2
3new positions
1sold out
$2.69avg. 13F price*
At the end of Q1 2025, 17 institutions reported holding Halozyme Therapeutics in (halo 0.25 03/01/27) in their 13F filings, up 2 from Q4 2024. 3 opened new positions and 1 sold out. The largest holders were Nomura Holdings Inc. ($18.7M), Sonora Investment Management Group, LLC ($4.2M) and New York State Common Retirement Fund ($3.2M).
- Company
- Halozyme Therapeutics in (halo 0.25 03/01/27)
- CUSIP
- 40637HAD1
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $89K |
| Exits | 1 | $2K |
All 13F filers, Q4 2024 → Q1 2025: 2,760,559 shares bought and 778,000 shares sold, net +1,982,559 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 17 holders
| Nomura Holdings Inc. | 0.10% | Add +1663.0% | 293,186 | $18.7M |
| Sonora Investment Management Group, LLC | 0.34% | Reduce -1.3% | 4,037,000 | $4.2M |
| New York State Common Retirement Fund | 0.00% | Reduce -18.6% | 3,063,000 | $3.2M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | Add +307.7% | 2,650,000 | $2.8M |
| Bank of New York Mellon Corp | 0.00% | Add +200.0% | 600,000 | $637K |
| Cetera Investment Advisers | 0.00% | No change | 171,000 | $181K |
| &partners | 0.00% | Reduce -2.8% | 140,000 | $148K |
| B. Riley Wealth Advisors, Inc. | 0.00% | New | 59,000 | $62K |
| Rollins Financial Advisors, LLC | 0.01% | No change | 54,000 | $57K |
| Mariner, LLC | 0.00% | No change | 54,000 | $57K |
| Choreo, LLC | 0.00% | Reduce -40.4% | 28,000 | $30K |
| MAI Capital Management | 0.00% | No change | 19,000 | $20K |
| Boussard & Gavaudan Investment Management LLP | 0.01% | New | 15,000 | $16K |
| Lanark Financial, Inc. | 0.00% | — | 13,000 | $13K |
| Comerica Bank | 0.00% | No change | 10,000 | $11K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | New | 10,000 | $11K |
| Laffer Tengler Investments, Inc. | 0.00% | Add +0.1% | 2,041 | $2K |
"% of holder's portfolio" is HALOZYME THERAPEUTICS IN (HALO 0.25 03/01/27)'s weight in each manager's 13F, not the share of Halozyme Therapeutics in (halo 0.25 03/01/27) the manager owns.